Intervention Review

You have free access to this content

Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders

  1. Douglas Wardrop1,
  2. Lise J Estcourt2,*,
  3. Susan J Brunskill3,
  4. Carolyn Doree3,
  5. Marialena Trivella4,
  6. Simon Stanworth2,
  7. Michael F Murphy5

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 29 JUL 2013

Assessed as up-to-date: 10 JAN 2013

DOI: 10.1002/14651858.CD009733.pub2


How to Cite

Wardrop D, Estcourt LJ, Brunskill SJ, Doree C, Trivella M, Stanworth S, Murphy MF. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD009733. DOI: 10.1002/14651858.CD009733.pub2.

Author Information

  1. 1

    Haematology, Oxford Cancer and Haematology Centre, Oxford, Oxfordshire, UK

  2. 2

    NHS Blood and Transplant, Haematology/Transfusion Medicine, Oxford, UK

  3. 3

    NHS Blood and Transplant, Systematic Review Initiative, Oxford, Oxon, UK

  4. 4

    University of Oxford, Centre for Statistics in Medicine, Oxford, UK

  5. 5

    John Radcliffe Hospital, NHS Blood and Transplant, Oxford, UK

*Lise J Estcourt, Haematology/Transfusion Medicine, NHS Blood and Transplant, Level 2, John Radcliffe Hospital, Headington, Oxford, OX3 9BQ, UK. lise.estcourt@nhsbt.nhs.uk. lestcourt@doctors.org.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 29 JUL 2013

SEARCH